IMDX Competitors & Alternatives
Compare Insight Molecular Diagnostics Inc. with similar stocks in the same industry
Diagnostics & Research
IMDX
Main Stock$1.66
+4.40%
Tradestie Score
48
Market Cap
$94.16M
Revenue Growth
115.0%
Analyst Upside
+336.7%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Other
Molecular Diagnostics
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDNA
CareDx, Inc.
|
$71.92
-3.39%
|
$798.40M | 31.5 | 39 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$24.78
-1.39%
|
$719.31M | - | 30 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.54
+0.18%
|
$719.23M | - | 47 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$33.41
+0.07%
|
$667.77M | - | 65 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$14.72
-1.74%
|
$612.76M | - | 56 | Compare |
|
LCTX
Lineage Cell Therapeutics, Inc.
|
$0.82
-2.21%
|
$385.92M | - | 57 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$16.36
+0.80%
|
$62.81M | - | 37 | Compare |
|
AKTX
Akari Therapeutics plc ADR (0.01 USD)
|
$6.71
+0.90%
|
$31.97M | - | 54 | Compare |
|
SYBX
Synlogic, Inc. Common Stock
|
$0.56
-50.00%
|
$19.89M | - | 42 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$1.54
+0.65%
|
$4.78M | - | 52 | Compare |
More IMDX Analysis
Data updated: Nov 19, 2026 | Industry: Diagnostics & Research (SIC 2835)
40 stocks in this industry